AbbVie Inc (ABBV)
160.33
-0.12
(-0.07%)
USD |
NYSE |
May 09, 16:00
160.41
+0.08
(+0.05%)
After-Hours: 20:00
AbbVie Gross Profit (Quarterly): 8.216B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.216B |
December 31, 2023 | 8.597B |
September 30, 2023 | 7.442B |
June 30, 2023 | 9.625B |
March 31, 2023 | 8.239B |
December 31, 2022 | 10.95B |
September 30, 2022 | 9.79B |
June 30, 2022 | 10.41B |
March 31, 2022 | 9.486B |
December 31, 2021 | 10.57B |
September 30, 2021 | 9.952B |
June 30, 2021 | 9.436B |
March 31, 2021 | 8.797B |
December 31, 2020 | 9.174B |
September 30, 2020 | 7.852B |
June 30, 2020 | 6.714B |
March 31, 2020 | 6.677B |
December 31, 2019 | 6.698B |
September 30, 2019 | 6.559B |
June 30, 2019 | 6.436B |
March 31, 2019 | 6.134B |
December 31, 2018 | 6.283B |
September 30, 2018 | 6.401B |
June 30, 2018 | 6.344B |
March 31, 2018 | 6.007B |
Date | Value |
---|---|
December 31, 2017 | 5.458B |
September 30, 2017 | 5.379B |
June 30, 2017 | 5.415B |
March 31, 2017 | 4.922B |
December 31, 2016 | 5.242B |
September 30, 2016 | 4.928B |
June 30, 2016 | 5.047B |
March 31, 2016 | 4.589B |
December 31, 2015 | 4.925B |
September 30, 2015 | 4.777B |
June 30, 2015 | 4.559B |
March 31, 2015 | 4.098B |
December 31, 2014 | 4.333B |
September 30, 2014 | 3.925B |
June 30, 2014 | 3.813B |
March 31, 2014 | 3.463B |
December 31, 2013 | 3.829B |
September 30, 2013 | 3.566B |
June 30, 2013 | 3.638B |
March 31, 2013 | 3.176B |
December 31, 2012 | 3.941B |
September 30, 2012 | 3.494B |
June 30, 2012 | 3.42B |
March 31, 2012 | 3.017B |
December 31, 2011 | 3.688B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
6.436B
Minimum
Jun 2019
10.95B
Maximum
Dec 2022
8.581B
Average
8.697B
Median
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 4.247B |
Johnson & Johnson | 14.87B |
Eli Lilly and Co | 7.094B |
Merck & Co Inc | 12.24B |
Pfizer Inc | 11.50B |